These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 16077146

  • 41. Prevalence and severity of anemia in pediatric hemodialysis patients.
    Azhir A, Nasiri J, Gheisari A.
    Saudi Med J; 2007 Feb; 28(2):249-53. PubMed ID: 17268705
    [Abstract] [Full Text] [Related]

  • 42. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis.
    Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, Gladziwa U, Rensma PL, Bartelet K, Konings CJ, Hoeks AP, Floege J, Leunissen KM.
    Nephrol Dial Transplant; 2006 May; 21(5):1293-9. PubMed ID: 16396973
    [Abstract] [Full Text] [Related]

  • 43. Predictors of vascular access thrombosis among patients on the cadaveric renal transplantation waiting list.
    Akman B, Afsar B, Ataç FB, Ibis A, Arat Z, Sezer S, Ozdemir FN, Haberal M.
    Transplant Proc; 2006 Mar; 38(2):413-5. PubMed ID: 16549134
    [Abstract] [Full Text] [Related]

  • 44. The association of lipid levels with mortality in patients on chronic peritoneal dialysis.
    Habib AN, Baird BC, Leypoldt JK, Cheung AK, Goldfarb-Rumyantzev AS.
    Nephrol Dial Transplant; 2006 Oct; 21(10):2881-92. PubMed ID: 16735386
    [Abstract] [Full Text] [Related]

  • 45. Interaction between parathyroid hormone and the Charlson comorbidity index on survival of incident haemodialysis patients.
    Morrone LF, Mazzaferro S, Russo D, Aucella F, Cozzolino M, Facchini MG, Galfrè A, Malberti F, Mereu MC, Nordio M, Pertosa G, Santoro D, CPCP Study Investigators.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2859-65. PubMed ID: 19369685
    [Abstract] [Full Text] [Related]

  • 46. The prognostic value of renal dysfunction in patients with chronic heart failure: 12-month follow-up.
    Roik M, Starczewska MH, Stawicki S, Solarska-Półchłopek A, Warszawik O, Oreziak A, Kochanowski J, Kosior D, Opolski G.
    Kardiol Pol; 2006 Jul; 64(7):704-11; discussion 712. PubMed ID: 16886127
    [Abstract] [Full Text] [Related]

  • 47. Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients.
    Rossert J, Gassmann-Mayer C, Frei D, McClellan W.
    Nephrol Dial Transplant; 2007 Mar; 22(3):794-800. PubMed ID: 17210593
    [Abstract] [Full Text] [Related]

  • 48. Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial.
    Anker SD, Voors A, Okonko D, Clark AL, James MK, von Haehling S, Kjekshus J, Ponikowski P, Dickstein K, OPTIMAAL Investigators.
    Eur Heart J; 2009 Jun; 30(11):1331-9. PubMed ID: 19383732
    [Abstract] [Full Text] [Related]

  • 49. [Comparative study of PTFE grafts in forearm vs cuffed permanent catheters].
    Moyano MJ, Salgueira M, Aresté N, Escalera B, del Toro N, Jiménez-Víbora E, Martínez-Puerto AI, Molas JR, Palma A.
    Nefrologia; 2006 Jun; 26(5):594-9. PubMed ID: 17117903
    [Abstract] [Full Text] [Related]

  • 50. Use of the femoral artery route for placement of temporary catheters for emergency haemodialysis when all usual central venous access sites are exhausted.
    Frampton AE, Kessaris N, Hossain M, Morsy M, Chemla ES.
    Nephrol Dial Transplant; 2009 Mar; 24(3):913-8. PubMed ID: 18952702
    [Abstract] [Full Text] [Related]

  • 51. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R, Besarab A, Macdougall IC, Ellison DH, Maxwell AP, Sulowicz W, Klinger M, Rutkowski B, Correa-Rotter R, Dougherty FC, BA 16528 Study Investigators.
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [Abstract] [Full Text] [Related]

  • 52. Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency.
    Sajgure A, Choudhury A, Ahmed Z, Choudhury D.
    Nephrol Dial Transplant; 2007 May; 22(5):1390-8. PubMed ID: 17267534
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Analysis of vascular access in hemodialysis patients: a report from a dialysis unit in Casablanca.
    Medkouri G, Aghai R, Anabi A, Yazidi A, Benghanem MG, Hachim K, Ramdani B, Zaid D.
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):516-20. PubMed ID: 17186686
    [Abstract] [Full Text] [Related]

  • 56. Impact of training in interventional nephrology on hemodialysis vascular access types.
    Haq NU, Sayeed S, Ali SA.
    Semin Dial; 2009 Dec; 22(1):90-2. PubMed ID: 19000113
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. High-efficiency short daily haemodialysis--morbidity and mortality rate in a long-term study.
    Martins Castro MC, Luders C, Elias RM, Abensur H, Romão Junior JE.
    Nephrol Dial Transplant; 2006 Aug; 21(8):2232-8. PubMed ID: 16632557
    [Abstract] [Full Text] [Related]

  • 59. Vascular access outcomes and medication use: a USRDS study.
    Yevzlin AS, Conley EL, Sanchez RJ, Young HN, Becker BN.
    Semin Dial; 2006 Aug; 19(6):535-9. PubMed ID: 17150056
    [Abstract] [Full Text] [Related]

  • 60. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients.
    Terrier N, Jaussent I, Dupuy AM, Morena M, Delcourt C, Chalabi L, Rouanet C, Canaud B, Cristol JP.
    Nephrol Dial Transplant; 2008 Jan; 23(1):345-53. PubMed ID: 17890748
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.